Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T14:55:38.186Z.
Calculation as of: 2026-10-06T14:55:38.186Z.
Quote observation: 2026-10-06T14:55:11.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: c6e002aca1a00fdff6499b7d77acdaecc7ea859b41a0df533897df39264525a0
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Adagio Medical Holdings, Inc.
Market Cap
$2.92M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.04M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.71M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.63M
Operating Cash Flow Yield
N/A
TTM Avg
0.03%
3Y Avg
0.03%
5Y Avg
0.03%
Market Cap
$3.25M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.27M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.32M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | $2.92M | N/A | N/A | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.04M | N/A | N/A | N/A | N/A |
| Jaguar Health, Inc. (JAGX)vs › | $2.71M | N/A | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.17M | N/A | N/A | N/A | N/A |
| Nuwellis, Inc. (NUWE)vs › | $2.64M | N/A | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.63M | N/A | 0.03% | 0.03% | 0.03% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.25M | N/A | N/A | N/A | N/A |
| IceCure Medical Ltd (ICCM)vs › | $3.27M | N/A | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.32M | N/A | N/A | N/A | N/A |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
